Nagata Toshi, Koide Yukio
Department of Health Science, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
J Biomed Biotechnol. 2010;2010:764542. doi: 10.1155/2010/764542. Epub 2010 May 24.
For protection against intracellular bacteria such as Mycobacterium tuberculosis and Listeria monocytogenes, the cellular arm of adaptive immunity is necessary. A variety of immunization methods have been evaluated and are reported to induce specific CD8(+) T cells against intracellular bacterial infection. Modified BCG vaccines have been examined to enhance CD8(+) T-cell responses. Naked DNA vaccination is a promising strategy to induce CD8(+) T cells. In addition to this strategy, live attenuated intracellular bacteria such as Shigella, Salmonella, and Listeria have been utilized as carriers of DNA vaccines in animal models. Vaccination with dendritic cells pulsed with antigenic peptides or the cells introduced antigen genes by virus vectors such as retroviruses is also a powerful strategy. Furthermore, vaccination with recombinant lentivirus has been attempted to induce specific CD8(+) T cells. Combinations of these strategies (prime-boost immunization) have been studied for the efficient induction of intracellular bacteria-specific CD8(+) T cells.
为了抵御细胞内细菌,如结核分枝杆菌和单核细胞增生李斯特菌,适应性免疫的细胞免疫分支是必不可少的。已经评估了多种免疫方法,据报道这些方法可诱导针对细胞内细菌感染的特异性CD8(+) T细胞。已对改良卡介苗进行了研究,以增强CD8(+) T细胞反应。裸DNA疫苗接种是诱导CD8(+) T细胞的一种有前景的策略。除了这种策略外,减毒活细胞内细菌,如志贺氏菌、沙门氏菌和李斯特菌,已在动物模型中用作DNA疫苗的载体。用抗原肽脉冲处理的树突状细胞或通过逆转录病毒等病毒载体导入抗原基因的细胞进行疫苗接种也是一种有效的策略。此外,已经尝试用重组慢病毒进行疫苗接种以诱导特异性CD8(+) T细胞。已经研究了这些策略的组合(初免-加强免疫),以有效诱导细胞内细菌特异性CD8(+) T细胞。